Company news
Neovasc Inc news in 2020
Neovasc Inc's news releases, calls and decks from 2020, newest first.
Neovasc Announces Publication of Peer-Reviewed Article in EuroIntervention
December 17, 2020
Neovasc Announces First Neovasc Reducer(TM) Implants in France
December 15, 2020
Neovasc Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency
December 14, 2020
Neovasc Receives Nasdaq Notification Regarding Minimum Market Value Deficiency
December 10, 2020
Neovasc Announces Closing of US$6.1 Million Registered Direct Offering Priced At-The-Market
December 10, 2020
Neovasc Announces US$6.1 Million Registered Direct Offering Priced At-the-Market
December 8, 2020
Neovasc Announces Participation in Noble Capital Markets Virtual Road Show Series
December 1, 2020
Neovasc to Participate in Canaccord Genuity 2020 Virtual MedTech & Diagnostics Forum
November 16, 2020
Neovasc Announces Third Quarter Financial Results
November 5, 2020
Neovasc Announces FDA Advisory Panel Result on Neovasc Reducer(TM) Medical Device for the Treatment of Refractory Angina
October 28, 2020
Neovasc to Report Third Quarter Financial Results on November 5, 2020
October 22, 2020
Neovasc to Sponsor Symposium on Treating Patients with Refractory Angina at TCT Connect 2020
October 13, 2020
Neovasc to Participate in H.C. Wainwright & Co. 22nd Annual Global Investment Conference
September 8, 2020
Neovasc Inc. Reports Results of Annual General Meeting of Shareholders
September 3, 2020
Neovasc Announces Partial Prepayment of Convertible Debenture
August 17, 2020
Neovasc Provides Corporate Update
August 13, 2020
Neovasc Announces Closing of US$12.6 Million Registered Direct Offering Priced At-The-Market
August 12, 2020
Neovasc Announces US$12.6 Million Registered Direct Offering Priced At-the-Market
August 10, 2020
Neovasc Announces Second Quarter Financial Results
August 6, 2020
Neovasc Reducer(TM) Featured In Germany's Second Largest National Newspaper
July 24, 2020
Neovasc Announces Partial Prepayment of Convertible Debenture
July 23, 2020
Neovasc Announces Circulatory System Devices Panel Meeting Date for Neovasc Reducer(TM) Device
July 9, 2020
Neovasc Provides Update on Second Quarter Results
July 6, 2020
Neovasc Reducer(TM) and Tiara(TM) Featured at Leading Industry Virtual Conferences
June 29, 2020
Neovasc Announces Positive Interim Results from REDUCER-I Study
June 26, 2020
Neovasc Regains Compliance with Nasdaq Minimum Market Value Rule
June 25, 2020
Neovasc Announces Closing of $11.5 Million Registered Direct Offering Priced At-The-Market
June 16, 2020
Neovasc Announces $11.5 Million Registered Direct Offering Priced At-The-Market
June 12, 2020
Neovasc Reducer(TM) and Tiara(TM) Program to be Highlighted at Leading Industry Virtual Conferences
June 9, 2020
Neovasc Announces Closing of Final Convertible Debt Issuance for Gross Proceeds of US$5.0 Million
June 4, 2020
Neovasc Reducer Spotlighted in Leading German Public Television Program
June 3, 2020
Neovasc Has Filed for CE Mark for Tiara TA Transapical Mitral Valve Replacement System
May 27, 2020
Neovasc Provides Corporate Update
May 26, 2020
Neovasc Announces Offering of Convertible Debt and Warrants for Gross Proceeds of up to US$5.0 Million, Warrant Exchange Transaction and Repayment of 2017 Convertible Notes and Related Settlement
May 26, 2020
Neovasc Announces First Quarter Financial Results
May 7, 2020
Neovasc Announces Receipt of Nasdaq Extension to Satisfy Market Cap Rule
May 1, 2020
Neovasc to Report First Quarter Financial Results on May 7, 2020
April 23, 2020
Neovasc Announces Fourth Quarter and Full Year 2019 Financial Results
March 30, 2020
Neovasc to Report Fourth Quarter and Full Year 2019 Financial Results on March 30, 2020
March 17, 2020
Neovasc Updates Investors at SVB Leerink 9th Annual Global Healthcare Conference
March 4, 2020
Neovasc Reducer Featured in Peer Reviewed EuroIntervention and PCR Online
March 3, 2020
Neovasc Will Request Nasdaq Hearing After Company Received Expected Delisting Determination From Nasdaq Staff
February 20, 2020
Neovasc to Participate in SVB Leerink 9th Annual Global Healthcare Conference on February 26, 2020
February 18, 2020
Neovasc Achieves Design Freeze for Transfemoral Trans-septal Tiara(TM) Mitral Valve System
February 12, 2020
Neovasc Initiates Independent Inquiry into Trading of Its Shares
February 11, 2020
Neovasc Provides Update on Nasdaq Compliance
February 3, 2020
Neovasc Announces Renewal of German Reimbursement NUB Status 1 Designation for Neovasc Reducer(TM) for Treatment of Refractory Angina
January 31, 2020
Neovasc Announces Executive Steering Committee for Transfemoral Trans-Septal Tiara Program
January 28, 2020
Neovasc Advances New Transfemoral Trans-Septal Tiara Design Concept After Further Successful Tests
January 24, 2020
Neovasc Reducer(TM) for Treatment of Refractory Angina Featured in Multiple Presentations in Germany
January 22, 2020
Decks in 2020
- EuroPCR 2020
Conference · 11 slides · June 2020